NO20031141L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20031141L
NO20031141L NO20031141A NO20031141A NO20031141L NO 20031141 L NO20031141 L NO 20031141L NO 20031141 A NO20031141 A NO 20031141A NO 20031141 A NO20031141 A NO 20031141A NO 20031141 L NO20031141 L NO 20031141L
Authority
NO
Norway
Prior art keywords
new connections
polypeptides
methods
genes listed
polymicleotides
Prior art date
Application number
NO20031141A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031141D0 (no
Inventor
Pankaj Agarwal
John P Cogswell
Ying-Ta Lai
Shelby A Martensen
Randall F Smith
Jay C Strum
Qing Xie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20031141D0 publication Critical patent/NO20031141D0/no
Publication of NO20031141L publication Critical patent/NO20031141L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20031141A 2000-09-13 2003-03-12 Nye forbindelser NO20031141L (no)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US23246300P 2000-09-13 2000-09-13
US23245500P 2000-09-13 2000-09-13
US23729300P 2000-10-02 2000-10-02
US24626900P 2000-11-07 2000-11-07
US25204900P 2000-11-20 2000-11-20
PCT/US2001/028462 WO2002022802A1 (en) 2000-09-13 2001-09-13 Novel compounds

Publications (2)

Publication Number Publication Date
NO20031141D0 NO20031141D0 (no) 2003-03-12
NO20031141L true NO20031141L (no) 2003-05-09

Family

ID=27540000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031141A NO20031141L (no) 2000-09-13 2003-03-12 Nye forbindelser

Country Status (16)

Country Link
US (1) US20070238151A1 (pl)
EP (1) EP1317538A4 (pl)
JP (1) JP2004508825A (pl)
KR (1) KR20030033055A (pl)
CN (2) CN1474869A (pl)
AU (2) AU2001292619B2 (pl)
BR (1) BR0113820A (pl)
CA (1) CA2421303A1 (pl)
CZ (1) CZ2003722A3 (pl)
HU (1) HUP0400016A3 (pl)
IL (1) IL154725A (pl)
MX (1) MXPA03002180A (pl)
NO (1) NO20031141L (pl)
NZ (2) NZ534259A (pl)
PL (1) PL361691A1 (pl)
WO (1) WO2002022802A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166132A1 (en) * 1998-08-26 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
US20030166522A1 (en) * 2000-12-12 2003-09-04 Ketchum Karen A. Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CN1252257C (zh) * 2001-03-02 2006-04-19 复旦大学 人类g型溶菌酶、其编码序列、制法及用途
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
AU2002359815A1 (en) * 2001-12-19 2003-07-09 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
WO2003091414A2 (en) * 2002-04-26 2003-11-06 Zymogenetics, Inc. Adipocyte complement related protein zacrp8
AU2002952993A0 (en) * 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
PL1606409T3 (pl) 2003-03-19 2011-02-28 Biogen Ma Inc Białko wiążące receptor Nogo
EP1608398A2 (en) * 2003-03-31 2005-12-28 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
BR0318307A (pt) * 2003-05-21 2006-07-11 Ares Trading Sa polipeptìdeo, molécula de ácido nucleico purificado, vetor, célula hospedeira, ligante, composto, método para diagnosticar uma doença em um paciente, uso de um polipeptìdeo, composição farmacêutica, composição de vacina, métodos para tratar uma doença para monitorar o tratamento terapêutico de doença em um paciente, método para a identificação de um composto que é efetivo no tratamento e/ou diagnóstico de doença, kit, e, animal não-humano transgênico ou knockout
AU2004249193A1 (en) * 2003-06-20 2004-12-29 Amgen Inc. Gene amplification and overexpression in cancer
PT1776136E (pt) 2004-06-24 2012-12-05 Biogen Idec Inc Tratamento de estados que envolvem desmielinização
US9093121B2 (en) 2006-02-28 2015-07-28 The Invention Science Fund I, Llc Data management of an audio data stream
US10003762B2 (en) 2005-04-26 2018-06-19 Invention Science Fund I, Llc Shared image devices
SI1904104T1 (sl) 2005-07-08 2013-12-31 Biogen Idec Ma Inc. Protitelesa SP35 in njihova uporaba
EP2315779A2 (en) 2008-07-09 2011-05-04 Biogen Idec MA Inc. Compositions comprising antibodies to lingo or fragments thereof
CA2780678A1 (en) 2009-11-19 2011-05-26 Ou Solis Biodyne Compositions for increasing polypeptide stability and activity, and related methods
US9796780B2 (en) 2012-05-14 2017-10-24 Biogen Ma Inc. LINGO-2 antagonists for treatment of conditions involving motor neurons
WO2016112270A1 (en) 2015-01-08 2016-07-14 Biogen Ma Inc. Lingo-1 antagonists and uses for treatment of demyelinating disorders
CN119351338B (zh) * 2023-09-15 2026-01-23 士泽生物医药（苏州）有限公司 一种表达cd300ld的低免疫原性细胞及其制备方法
CN120699089A (zh) * 2024-03-25 2025-09-26 中国农业大学 一种具glp-1受体激动剂活性的乳清蛋白源降血糖肽的制备及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0997476A3 (en) * 1998-09-25 2000-07-19 Schering-Plough Antibodies to a mammalian Langerhans cell antigen and their uses
AU2001243142A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US20020012967A1 (en) * 2000-03-10 2002-01-31 Holloway James L. Insulin homolog polypeptide zins4
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
JP3785029B2 (ja) * 2000-08-04 2006-06-14 株式会社山武 制御装置および制御方法
CA2431144A1 (en) * 2000-12-18 2002-08-01 Incyte Genomics, Inc. Cell adhesion proteins
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides

Also Published As

Publication number Publication date
NO20031141D0 (no) 2003-03-12
CN1680441A (zh) 2005-10-12
MXPA03002180A (es) 2004-12-13
EP1317538A4 (en) 2005-04-06
WO2002022802A1 (en) 2002-03-21
NZ524328A (en) 2004-09-24
JP2004508825A (ja) 2004-03-25
IL154725A0 (en) 2003-10-31
PL361691A1 (pl) 2004-10-04
NZ534259A (en) 2006-05-26
CN1474869A (zh) 2004-02-11
CZ2003722A3 (en) 2004-03-17
CA2421303A1 (en) 2002-03-21
KR20030033055A (ko) 2003-04-26
AU9261901A (en) 2002-03-26
HUP0400016A2 (hu) 2004-04-28
HUP0400016A3 (en) 2006-01-30
US20070238151A1 (en) 2007-10-11
IL154725A (en) 2003-12-23
EP1317538A1 (en) 2003-06-11
AU2001292619B2 (en) 2006-01-12
BR0113820A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
NO20025151L (no) Nye forbindelser
PT1370571E (pt) Processos e aparelhos para analises qualitativas e quantitativas, isentas de gel, do proteoma e as suas utilizacoes
WO2002002636A3 (en) Membrane associated protein zupari
WO2002090520A3 (en) Toll/interleukin-1 receptor adaptor protein (tirap)
MXPA03000227A (es) Compuestos novedosos.
BRPI0418229A (pt) genes do ciclo celular e métodos corrrelatos de uso
BR0113820A (pt) Compostos
NO20030495D0 (no) Peptider som presenteres av celler
WO2001066690A3 (en) Novel compounds
PA8577701A1 (es) Polipeptido t20 pegilado
WO2001072961A3 (en) Novel compounds
NO20053595L (no) Escitalopramdibromid samt fremgangsmate ved fremstilling derav.
GB9811260D0 (en) Novel compounds
WO2002004600A3 (en) Novel compounds
DK1303539T3 (da) Hidtil ukendt medlem af EphA-receptorfamilien
ATE319739T1 (de) Menschliche wingless-änhliche gene
DK1257573T3 (da) Hidtil ukendt transskriptionsfaktor CARP-2
NO20016340L (no) Hodetraumeindusert cytoplasmatisk kalsiumbindende protein
ATE414717T1 (de) Neuromedin u delta polypeptide
ATE443715T1 (de) Polypeptide aus haemophilus influenza
WO2002014355A3 (en) Novel mitogen activated kinase
WO2001055428A3 (en) Mprot45 metalloprotease
WO2002008252A3 (en) Novel protein containing ring finger domaine r1p4
WO2004020983A3 (en) Ultrafiltration device for drug binding studies
WO2001085937A3 (en) Regulator of g protein signalling (rgs8)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application